Alpha-gal syndrome: Implications for cardiovascular disease

John Bianchi, Anneke Walters, Zachary W Fitch, Joseph W Turek

Abstract


Alpha-gal syndrome (AGS) refers to a potentially life-threatening allergy to the molecule galactose-α1,3-galactose (gal), which is expressed on most mammalian tissues but, importantly, is not expressed by humans. This syndrome can manifest as an allergic reaction to mammalian meat products, but other sources of mammalian tissue can also provoke an immune response, including injectable and implantable medical products. This syndrome has been linked to coronary atherosclerosis, and medical products that express gal are routinely used in cardiology and cardiac surgery. This article seeks to discuss potential implications of alpha syndrome as it relates to cardiovascular health and to heighten awareness in the cardiovascular community about this emerging public health issue.


Full Text:

PDF


DOI: http://dx.doi.org/10.21542/gcsp.2019.20

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 John Bianchi, Anneke Walters, Zachary W Fitch, Joseph W Turek

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.